Enhancement of antibody-induced arthritis via Toll-like receptor 2 stimulation is regulated by granulocyte reactive oxygen species
2012 (English)In: American Journal of Pathology, ISSN 0002-9440, E-ISSN 1525-2191, Vol. 181, no 1, p. 141-150Article in journal (Refereed) Published
Abstract [en]
The suppressive role of phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX2) complex-derived reactive oxygen species (ROS) in adaptive immunity-driven arthritis models is well established. In this study, we aimed to investigate the role of NOX2 complex-derived ROS in a model of innate immunity-driven arthritis and to identify the ROS-regulated innate receptors that control arthritis. We used collagen antibody-induced arthritis (CAIA), which is a T and B lymphocyte-independent model of the effector phase of arthritis and is induced by well-defined monoclonal arthritogenic antibodies and enhanced by injection of lipopolysaccharide (LPS). CAIA was induced in both wild-type and Ncf1 mutant mice that lack phagocyte oxidative burst, and stimulated with LPS and other agents to activate innate immune responses. We found that both LPS and lipomannan enhanced CAIA more potently in the presence of functional phagocyte ROS production than in its absence. The ROS-dependent enhancement of CAIA was regulated by TLR2, but not by TLR4 stimulation, and was driven by granulocytes, whereas macrophages did not contribute to the phenotype. In addition, we report that collagen-induced arthritis was not affected by the functionality of the TLR4. We report that TLR2 signaling as an important ROS-regulated proinflammatory pathway leads to severe neutrophil-dependent inflammation in murine CAIA and conclude that the TLR2 pathway is modulated by phagocyte ROS to stimulate the development of arthritis. © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Place, publisher, year, edition, pages
New York, NY: Elsevier, 2012. Vol. 181, no 1, p. 141-150
National Category
Rheumatology and Autoimmunity
Identifiers
URN: urn:nbn:se:hh:diva-48873DOI: 10.1016/j.ajpath.2012.03.031ISI: 000305851100015PubMedID: 22642907Scopus ID: 2-s2.0-84862668677OAI: oai:DiVA.org:hh-48873DiVA, id: diva2:1718794
Note
Funding text: Supported by the Sigrid Juselius Foundation, Academy of Finland, Nordic Center of Excellence in Disease Genetics, Maire Lisko Foundation, the Swedish Science Strategic Foundation (SSF), and the EU project Master-switch (HEALTH-F2-2008-223404).
2022-12-132022-12-132023-02-16Bibliographically approved